These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19679675)

  • 1. Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat.
    Baumann MH; Zolkowska D; Kim I; Scheidweiler KB; Rothman RB; Huestis MA
    Drug Metab Dispos; 2009 Nov; 37(11):2163-70. PubMed ID: 19679675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
    Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
    Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
    Concheiro M; Baumann MH; Scheidweiler KB; Rothman RB; Marrone GF; Huestis MA
    Drug Metab Dispos; 2014 Jan; 42(1):119-25. PubMed ID: 24141857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration.
    Hartman RL; Desrosiers NA; Barnes AJ; Yun K; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA
    Anal Bioanal Chem; 2014 Jan; 406(2):587-99. PubMed ID: 24232751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats.
    Hirt D; Fonsart J; Menet MC; Debray M; Noble F; Declèves X; Scherrmann JM
    Toxicol Sci; 2010 Mar; 114(1):38-47. PubMed ID: 20008456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
    Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).
    Fonsart J; Menet MC; Debray M; Hirt D; Noble F; Scherrmann JM; Declèves X
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):339-47. PubMed ID: 19781562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice.
    Scheidweiler KB; Ladenheim B; Barnes AJ; Cadet JL; Huestis MA
    J Anal Toxicol; 2011 Sep; 35(7):470-80. PubMed ID: 21871156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
    Segura M; Farré M; Pichini S; Peiró AM; Roset PN; Ramírez A; Ortuño J; Pacifici R; Zuccaro P; Segura J; de la Torre R
    Clin Pharmacokinet; 2005; 44(6):649-60. PubMed ID: 15910012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
    Valtier S; Phelix CF; Cody JT
    J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.
    Barnes AJ; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA
    Ther Drug Monit; 2011 Oct; 33(5):602-8. PubMed ID: 21860342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
    Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA
    J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.
    Mueller M; Goodwin AK; Ator NA; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2011 Jul; 338(1):310-7. PubMed ID: 21493752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
    Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F
    Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
    Mueller M; Yuan J; Felim A; Neudörffer A; Peters FT; Maurer HH; McCann UD; Largeron M; Ricaurte GA
    Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.
    Farré M; Tomillero A; Pérez-Mañá C; Yubero S; Papaseit E; Roset PN; Pujadas M; Torrens M; Camí J; de la Torre R
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1637-49. PubMed ID: 26073279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.
    Mechan A; Yuan J; Hatzidimitriou G; Irvine RJ; McCann UD; Ricaurte GA
    Neuropsychopharmacology; 2006 Feb; 31(2):339-50. PubMed ID: 15999148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
    de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
    Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.
    Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
    Clin Chem; 2011 Dec; 57(12):1748-56. PubMed ID: 21980168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration.
    Barnes AJ; De Martinis BS; Gorelick DA; Goodwin RS; Kolbrich EA; Huestis MA
    Clin Chem; 2009 Mar; 55(3):454-62. PubMed ID: 19168553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.